A possible vaccine for Lyme disease is entering its final round of clinical trials.
- The vaccine, known VLA15, was developed by Pfizer and French drug company Valneva. They're hoping for full authorization by the year 2025.
- If approved, VAL15 would be the only Lyme disease vaccine available in the U.S.
- After seeing how quickly the COVID-19 vaccines were developed and approved, should other vaccine development be done more quickly?